From weight loss drugs to tackling sleep disorders! Eli Lilly plans to acquire Centessa for up to $7.8 billion, entering the treatment field for narcolepsy and wakefulness disorders.
```
Eli Lilly is leveraging its strong capital accumulated in the obesity field to bet on the next high-potential health sector.
The American pharmaceutical giant announced that it will acquire the biotechnology company Centessa Pharmaceuticals for up to $7.8 billion, marking the second largest acquisition in Lilly’s history. Centessa